Ocular Imaging for Monitoring of Ocular Tumor Disease
Memorial Sloan Kettering Cancer Center
Summary
The purpose of this study is to compare two devices used for optical coherence tomography (OCT). OCT is a noninvasive imaging (scanning) method that uses reflected light to create pictures of the back of the eye, and doctors can use OCT to detect and monitor different types of cancer
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Age ≥18 years. * At least 1 eye that has an intraocular or ocular surface tumor. * The presence of a natural crystalline lens or intraocular lens. * Pupils that can dilate up to at least 3 mm in the study eyes. * The absence of opaque natural crystalline lenses or the presence of any ocular disease that prevents the view of the retina for imaging. * Patients must be able to fixate on the imaging target. * Patients must be able to sit still for a period of time (approximately 2 minutes). Exclusion Criteria: * Does not meet ALL of the above conditions
Interventions
- Diagnostic TestIntalight Dream OCT
This is a next-generation swept-source device that has a faster imaging speed and higher sensitivity than the previous generation of frequency-domain OCT devices, which serve as the current standard of care devices.
- Diagnostic TestHeidelberg Spectralis OCT
This is the standard of care for optical imaging.
Locations (7)
- Memorial Sloan Kettering at Basking Ridge (Consent Only)Basking Ridge, New Jersey
- Memorial Sloan Kettering Monmouth (Consent only)Middletown, New Jersey
- Memorial Sloan Kettering Bergen (Consent Only)Montvale, New Jersey
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)Commack, New York
- Memorial Sloan Kettering Westchester (Consent Only)Harrison, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites)New York, New York